Bao P,Mi J,Yu Z,Liu L,Zhu Z,Liu S,Nan Z S .2021 .Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis. Medicine (Baltimore), 100(43) : e27658.
Chertow GM,Vart P,Jongs N,Toto RD,Gorriz JL,Hou FF,McMurray JJV,Correa-Rotter R,Rossing P,Sjostrom CD,Stefánsson BV,Langkilde AM,Wheeler DC,Heerspink HJL .2021 .Effects of dapagliflozin in stage 4 chronic kidney disease. J. Am. Soc. Nephrol., 32(9) : 2352-2361.
Cocchi C,Coppi F,Farinetti A,Mattioli AV .2021 .Cardiovascular disease prevention and therapy in women with Type 2 diabetes. , 17(3) : 487-496.
Campione JR,Ritchie ND,Fishbein HA,Mardon RE,Johnson MC,Pace W,Birch RJ,Seeholzer EL,Zhang X,Proia K,Siegel KR,McKeever Bullard K KR .2022 .Use and Impact of Type 2 Diabetes Prevention Interventions. Am. J. Prev. Med, 63(4) : 603-610.
Dugani SB,Mielke MM,Vella A .2021 .Burden and management of type 2 diabetes in rural United States. Diabetes Metab. Res. Rev., 37(5) : e3410.
Dou Z,Xia Y,Zhang J,Li Y,Zhang Y,Zhao L,Huang Z,Sun H,Wu L,Han D,Liu Y .2021 .Syndrome differentiation and treatment regularity in traditional Chinese medicine for type 2 diabetes: A text mining analysis. Front Endocrinol (Lausanne), 12(1) : 728032.
Guo Z and Priefer R .2021 .Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview. Diabetes Metab. Syndr., 15(5) : 102239.
Jongs N,Greene T,Chertow GM,McMurray JJV,Langkilde AM,Correa-Rotter R,Rossing P,Sjostrom CD,Stefansson BV,Toto RD,Wheeler DC,Heerspink HJL .2021 .Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: A prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol., 9(11) : 755-766.
Karagiannis T,Tsapas A,Athanasiadou E,Avgerinos I,Liakos A,Matthews DR,Bekiari E .2021 .GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res. Clin. Pract, 174(12) : 108737.
Kurian J,Mohanthy S,Nanjumdaiah RM .2022 .Mechanism of action of yoga on prevention and management of type 2 diabetes mellitus: Narrative review. J. Bodyw. Mov. Ther., 29(3) : 134-139.
Leccisotti L,Cinti F,Sorice GP,D'Amario D,Lorusso M,Guzzardi MA,Mezza T,Gugliandolo S,Cocchi C,Capece U,Indovina L,Ferraro PM,Iozzo P,Crea F,Giordano A,Giaccari A .2022 .Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: The DAPAHEART Trial: A preliminary report. , 21(1) : 173.
Ma CX,Ma XN,Guan CH,Li YD,Mauricio D,Fu SB D .2022 .Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management. Cardiovasc Diabetol, 21(1) : 74.
Rizzo MR,Di Meo I,Polito R,Auriemma MC,Gambardella A,di Mauro G,Capuano A,Paolisso G .2022 .Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment. Pharmacol. Res., 176(11) : 106062.
Siasos G .2020 .Diabetes and cardiovascular disease. Curr. Pharm. Des., 26(46) : 5909-5910.
Tinajero MG,Malik VS .2021 .An update on the epidemiology of type 2 diabetes: A global perspective. Endocrinol. Metab. Clin. North. Am., 50(3) : 337-355.
Tamborlane WV,Laffel LM,Shehadeh N,Isganaitis E,Van Name M,Ratnayake J,Karlsson C,Norjavaara E .2022 .Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: A prospective, multicentre, randomised, parallel group, phase 3 study. Lancet Diabetes Endocrinol., 10(5) : 341-350.
Wiviott SD,Raz I,Bonaca MP,Mosenzon O,Kato ET,Cahn A,Silverman MG,Zelniker TA,Kuder JF,Murphy SA,Bhatt DL,Leiter LA,McGuire DK,Wilding JPH,Ruff CT,Gause-Nilsson IAM,Fredriksson M,Johansson PA,Langkilde AM,Sabatine MS .2019 .Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N. Engl. J. Med, 380(4) : 347-357.
Zelniker TA,Wiviott SD,Raz I,Im K,Goodrich EL,Bonaca MP,Mosenzon O,Kato ET,Cahn A,Furtado RHM,Bhatt DL,Leiter LA,McGuire DK,Wilding JPH,Sabatine MS .2019 .SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials. Lancet., 393(10166) : 31-39.
Zhao X,Liu L,Liu J .2022 .Treatment of type 2 diabetes mellitus using the traditional Chinese medicine Jinlida as an add-on medication: A systematic review and meta-analysis of randomized controlled trials. Front. Endocrinol. (Lausanne), 13(5) : 1018450.
Zhang Y,Hou J,Zeng Z J .2022 .Analysis of prescription medication rules of traditional Chinese medicine for diabetes treatment based on data mining. J. Healthc Eng, 7653765 : .